Literature DB >> 19089624

Pathophysiological aspects of the formation of neurological deficit in multiple sclerosis.

A V Peresedova1, E V Baidina, O V Trifonova, O S Korepina, V V Gnezditskii, M V Krotenkova, R N Konovalov, L A Chernikova, N S Alekseeva, I M Kirichenko, O Yu Rebrova, I A Zavalishin.   

Abstract

The results of complex studies were used to formulate a concept of the development of neurological impairments in multiple sclerosis (MS). Acutely developing impairments to spike propagation, reaching the level of conduction blockade, due to the active pathological process with demyelinating and axonal damage to the CNS lead to the formation of neurological impairments in exacerbations of MS, while complete or partial reversion (regression) of these symptoms in the stage of remission results from compensatory changes in the nature of conduction, which were not, however, accompanied by recovery of electrophysiological measures. The development of stable neurological deficit in secondary-progressive MS is determined by impairments to spike conduction processes associated with significant levels of demyelination and atrophic changes in the CNS, with myelin loss and axon death. Finally, the severity of cognitive changes is determined by differences in the severities of both the focal demyelinating process and diffuse damage to brain substance in MS, including the neurodegenerative component. The main factor in transient increases in symptoms is the universal lability of electrophysiological parameters, including those developing on the background of ion and neurotransmitter imbalance.

Entities:  

Mesh:

Year:  2009        PMID: 19089624     DOI: 10.1007/s11055-008-9101-7

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  31 in total

1.  Axonal changes in chronic demyelinated cervical spinal cord plaques.

Authors:  G Lovas; N Szilágyi; K Majtényi; M Palkovits; S Komoly
Journal:  Brain       Date:  2000-02       Impact factor: 13.501

2.  Conduction in segmentally demyelinated mammalian central axons.

Authors:  P A Felts; T A Baker; K J Smith
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

3.  Circulating toxic factors in multiple sclerosis: a perspective.

Authors:  C L Schauf; F A Davis
Journal:  Adv Neurol       Date:  1981

4.  Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells.

Authors:  O Honmou; P A Felts; S G Waxman; J D Kocsis
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

5.  Effects of induced hyperthermia on visual evoked potentials and saccade parameters in normal subjects and multiple sclerosis patients.

Authors:  S Bajada; F L Mastaglia; J L Black; D W Collins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-09       Impact factor: 10.154

Review 6.  Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences.

Authors:  C Bjartmar; B D Trapp
Journal:  Curr Opin Neurol       Date:  2001-06       Impact factor: 5.710

7.  Changed distribution of sodium channels along demyelinated axons.

Authors:  J D England; F Gamboni; S R Levinson; T E Finger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

Authors:  B D Youl; G Turano; D H Miller; A D Towell; D G MacManus; S G Moore; S J Jones; G Barrett; B E Kendall; I F Moseley
Journal:  Brain       Date:  1991-12       Impact factor: 13.501

9.  Changes in nystagmus on raising body temperature in clinically suspected and proved multiple sclerosis.

Authors:  J V Jestico; P D Ellis
Journal:  Br Med J       Date:  1976-10-23

10.  Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex.

Authors:  Brigitte Voutsinos-Porche; Gilles Bonvento; Kohichi Tanaka; Pascal Steiner; Egbert Welker; Jean-Yves Chatton; Pierre J Magistretti; Luc Pellerin
Journal:  Neuron       Date:  2003-01-23       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.